Loading clinical trials...
Loading clinical trials...
Tissue Bank for Studies Related to Graft-Versus-Host Disease (GVHD)
RATIONALE: Collecting and storing samples of blood, urine, and tissue from patients undergoing a donor stem cell transplant to test in the laboratory may help the study of graft-versus-host disease in the future. PURPOSE: This research study is collecting and storing tissue and DNA samples from patients undergoing a donor stem cell transplant.
OBJECTIVES: * To establish a DNA bank from donor and recipient (prior to transplant) peripheral blood for SNP studies. * To establish a tissue bank for gene expression studies using donor and recipient (post-transplant) peripheral blood samples. * To establish a tissue bank for proteomic studies using donor and recipient blood and urine samples. * To establish a tissue bank for various studies using biopsy specimens. * To establish a tissue bank for flow cytometric studies using recipient (post-transplant), and sample from stem cell product. OUTLINE: Peripheral blood samples are collected from donors prior to stem cell mobilization and from patients prior to starting preparative regimen. Samples are studied by single nucleotide polymorphism (SNP) analysis, SNP array, proteomic analysis, gene expression, and other immunological laboratory methods. Blood, urine, and tissue samples are preserved for future studies. Extra skin biopsies and gastrointestinal biopsies are performed at diagnosis of graft-vs-host disease and preserved in a tissue bank for flow cytometric studies.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center at Franklin
Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Start Date
January 1, 2007
Primary Completion Date
March 1, 2010
Completion Date
March 1, 2010
Last Updated
November 6, 2012
190
ACTUAL participants
gene expression analysis
GENETIC
microarray analysis
GENETIC
polymorphism analysis
GENETIC
proteomic profiling
GENETIC
flow cytometry
OTHER
immunologic technique
OTHER
laboratory biomarker analysis
OTHER
biopsy
PROCEDURE
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Collaborators
NCT05673200
NCT05372640
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions